WARRANT AGREEMENTWarrant Agreement • October 22nd, 2012 • Cleveland Biolabs Inc • Services-commercial physical & biological research • New York
THIS WARRANT AGREEMENT made as of October [_], 2012 (the “Issuance Date”), between Cleveland BioLabs, Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Warrant Agent”).
Cleveland BioLabs, Inc. 7,500,000 Shares of Common Stock Warrants to Purchase 3,750,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 22nd, 2012 • Cleveland Biolabs Inc • Services-commercial physical & biological research • New York
The Company has prepared and filed in conformity with the requirements of the Securities Act of 1933, as amended (the “Securities Act”), and the published rules and regulations thereunder (the “Rules”) adopted by the Securities and Exchange Commission (the “Commission”) a “shelf” registration statement on Form S-3 (No. 333-167258), which became effective as of June 17, 2010, including a base prospectus (the “Base Prospectus”), in accordance with Rule 415 of the Securities Act and such amendments thereof as may have been required to the date of this Agreement. Copies of such Registration Statement (including all amendments thereof and all documents deemed incorporated by reference therein) and of the related Base Prospectus have heretofore been delivered by the Company or are otherwise available to you.
